Partillion Updates
Partillion Bioscience Corporation Announces Seed Financing, Expanded Board, and New Partnership with Alloy Therapeutics
Financing will fund growth and expansion of new functional single-cell analysis and sorting product lines for drug discovery, enabled by Partillion's proprietary Nanovial technology.
Partillion Wins Top New Product Award at SLAS 2022
We are excited to announce that our Nanovial product was selected for the top New Product award at the Society of Laboratory Automation and Screening International Conference and Exhibition that took place in Boston, MA on February 7th, 2022.
Partillion Selected as Finalist for Multiple Awards at SLAS 2022
Partillion Bioscience has been nominated for multiple awards at the upcoming Society for Laboratory Automation and Screening annual meeting.
Partillion Co-Founder Awarded 2020 SLAS Innovation Award
The most prestigious award of the conference, the SLAS Innovation Award, was given to Joseph De Rutte, M.S., (University of California Los Angeles, CA, USA) for his scientific podium presentation, “High-Throughput Encapsulation and Selection of Cells Based on Antibody Secretion Using Lab-on-a-Particle Technology.”